The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| 2Seventy Bio Inc | COMMON STOCK | 901384107 | 4,654 | 459,836 | SH | OTR | 459,836 | 0 | 0 | |||
| 89Bio Inc | COM | 282559103 | 39,795 | 2,100,000 | SH | OTR | 2,100,000 | 0 | 0 | |||
| Akero Therapeutics Inc | COM | 00973Y108 | 78,287 | 1,676,733 | SH | OTR | 1,676,733 | 0 | 0 | |||
| Alaunos Therapeutics Inc | COM | 98973P101 | 765 | 1,500,000 | SH | OTR | 1,500,000 | 0 | 0 | |||
| Amicus Therapeutics Inc | COM | 03152W109 | 29,202 | 2,325,000 | SH | OTR | 2,325,000 | 0 | 0 | |||
| Amylyx Pharmaceuticals Inc | COM | 03237H101 | 44,952 | 2,084,000 | SH | OTR | 2,084,000 | 0 | 0 | |||
| AnaptysBio Inc | COM | 032724106 | 26,442 | 1,300,000 | SH | OTR | 1,300,000 | 0 | 0 | |||
| Apellis Pharmaceuticals Inc | COM | 03753U106 | 143,574 | 1,576,000 | SH | OTR | 1,576,000 | 0 | 0 | |||
| Arcus Biosciences Inc | COM | 03969F109 | 32,541 | 1,602,200 | SH | OTR | 1,602,200 | 0 | 0 | |||
| Argenx SE | SPONSORED ADR | 04016X101 | 29,230 | 75,000 | SH | OTR | 75,000 | 0 | 0 | |||
| Ascendis Pharma A/S | SPONSORED ADR | 04351P101 | 8,479 | 95,000 | SH | OTR | 95,000 | 0 | 0 | |||
| Atreca Inc | CL A COM | 04965G109 | 2,158 | 2,202,333 | SH | OTR | 2,202,333 | 0 | 0 | |||
| Avidity Biosciences Inc | COM | 05370A108 | 12,436 | 1,121,327 | SH | OTR | 1,121,327 | 0 | 0 | |||
| Axsome Therapeutics Inc | COM | 05464T104 | 28,744 | 400,000 | SH | OTR | 400,000 | 0 | 0 | |||
| BeiGene Ltd | SPONSORED ADR | 07725L102 | 89,150 | 500,000 | SH | OTR | 500,000 | 0 | 0 | |||
| Bellicum Pharmaceuticals Inc | COM NEW | 079481404 | 167 | 450,000 | SH | OTR | 450,000 | 0 | 0 | |||
| BioAtla Inc | COM | 09077B104 | 2,059 | 686,347 | SH | OTR | 686,347 | 0 | 0 | |||
| Black Diamond Therapeutics I | COM | 09203E105 | 10,175 | 2,014,858 | SH | OTR | 2,014,858 | 0 | 0 | |||
| Cabaletta Bio Inc | COM | 12674W109 | 6,971 | 540,000 | SH | OTR | 540,000 | 0 | 0 | |||
| Centessa Pharmaceuticals PLC | SPONSORED ADS | 152309100 | 7,745 | 1,251,137 | SH | OTR | 1,251,137 | 0 | 0 | |||
| Cogent Biosciences Inc | COM | 19240Q201 | 6,216 | 525,000 | SH | OTR | 525,000 | 0 | 0 | |||
| Cullinan Oncology Inc | COM | 230031106 | 11,557 | 1,074,082 | SH | OTR | 1,074,082 | 0 | 0 | |||
| Cytokinetics Inc | COM NEW | 23282W605 | 68,502 | 2,100,000 | SH | OTR | 2,100,000 | 0 | 0 | |||
| Day One Biopharmaceuticals I | COM | 23954D109 | 14,208 | 1,189,943 | SH | OTR | 1,189,943 | 0 | 0 | |||
| DBV Technologies S A | SPONSORED ADR | 23306J101 | 2,755 | 1,450,000 | SH | OTR | 1,450,000 | 0 | 0 | |||
| Disc Medicine Inc | COM | 254604101 | 5,772 | 130,000 | SH | OTR | 130,000 | 0 | 0 | |||
| Enliven Therapeutics Inc | COM | 29337E102 | 14,504 | 710,644 | SH | OTR | 710,644 | 0 | 0 | |||
| EQRx Inc | COM | 26886C107 | 1,860 | 1,000,000 | SH | OTR | 1,000,000 | 0 | 0 | |||
| Exelixis Inc | COM | 30161Q104 | 21,977 | 1,150,000 | SH | OTR | 1,150,000 | 0 | 0 | |||
| Fate Therapeutics Inc | COM | 31189P102 | 2,380 | 500,000 | SH | OTR | 500,000 | 0 | 0 | |||
| Geron Corp | COM | 374163103 | 9,630 | 3,000,000 | SH | OTR | 3,000,000 | 0 | 0 | |||
| Gossamer Bio Inc | COM | 38341P102 | 4,004 | 3,336,928 | SH | OTR | 3,336,928 | 0 | 0 | |||
| Ideaya Biosciences Inc | COM | 45166A102 | 51,766 | 2,202,812 | SH | OTR | 2,202,812 | 0 | 0 | |||
| ImmunoGen Inc | COM | 45253H101 | 55,874 | 2,961,000 | SH | OTR | 2,961,000 | 0 | 0 | |||
| Iovance Biotherapeutics Inc | COM | 462260100 | 26,084 | 3,705,133 | SH | OTR | 3,705,133 | 0 | 0 | |||
| iTeos Therapeutics Inc | COM | 46565G104 | 28,520 | 2,154,058 | SH | OTR | 2,154,058 | 0 | 0 | |||
| Iveric Bio Inc | COM | 46583P102 | 32,456 | 825,000 | SH | OTR | 825,000 | 0 | 0 | |||
| Kalvista Pharmaceuticals Inc | COM | 483497103 | 14,850 | 1,650,000 | SH | OTR | 1,650,000 | 0 | 0 | |||
| Karuna Therapeutics Inc | COM | 48576A100 | 54,213 | 250,000 | SH | OTR | 250,000 | 0 | 0 | |||
| Kinnate Biopharma Inc | COM | 49705R105 | 1,488 | 491,000 | SH | OTR | 491,000 | 0 | 0 | |||
| Legend Biotech Corp | SPONSORED ADS | 52490G102 | 41,418 | 600,000 | SH | OTR | 600,000 | 0 | 0 | |||
| Madrigal Pharmaceuticals Inc | COM | 558868105 | 23,100 | 100,000 | SH | OTR | 100,000 | 0 | 0 | |||
| MEI Pharma Inc | COM NEW | 55279B202 | 958 | 145,654 | SH | OTR | 145,654 | 0 | 0 | |||
| Mereo Biopharma Group PLC | SPON ADS | 589492107 | 2,970 | 2,250,000 | SH | OTR | 2,250,000 | 0 | 0 | |||
| Mersana Therapeutics Inc | COM | 59045L106 | 3,290 | 1,000,000 | SH | OTR | 1,000,000 | 0 | 0 | |||
| Merus N V | COM | N5749R100 | 50,027 | 1,900,000 | SH | OTR | 1,900,000 | 0 | 0 | |||
| Milestone Pharmaceuticals In | COM | 59935V107 | 1,992 | 698,861 | SH | OTR | 698,861 | 0 | 0 | |||
| Mirati Therapeutics Inc | COM | 60468T105 | 72,260 | 2,000,000 | SH | OTR | 2,000,000 | 0 | 0 | |||
| NGM Biopharmaceuticals Inc | COM | 62921N105 | 1,295 | 500,000 | SH | OTR | 500,000 | 0 | 0 | |||
| Nurix Therapeutics Inc | COM | 67080M103 | 12,237 | 1,224,892 | SH | OTR | 1,224,892 | 0 | 0 | |||
| Nuvalent Inc | COM | 670703107 | 51,034 | 1,210,192 | SH | OTR | 1,210,192 | 0 | 0 | |||
| Nuvation Bio Inc | *W EXP 07/07/202 | 67080N119 | 44 | 266,666 | SH | OTR | 266,666 | 0 | 0 | |||
| Orchestra Biomed Hldgs Inc | COM | 68572M106 | 1,750 | 250,000 | SH | OTR | 250,000 | 0 | 0 | |||
| Oric Pharmaceuticals Inc | COM | 68622P109 | 13,445 | 1,732,571 | SH | OTR | 1,732,571 | 0 | 0 | |||
| PMV Pharmaceuticals Inc | COM | 69353Y103 | 19,805 | 3,163,795 | SH | OTR | 3,163,795 | 0 | 0 | |||
| Point Biopharma Global Inc | COM | 730541109 | 22,650 | 2,500,000 | SH | OTR | 2,500,000 | 0 | 0 | |||
| Prelude Therapeutics Inc | COM | 74065P101 | 11,228 | 2,495,018 | SH | OTR | 2,495,018 | 0 | 0 | |||
| Protara Therapeutics Inc | COM STK | 74365U107 | 500 | 209,227 | SH | OTR | 209,227 | 0 | 0 | |||
| Prothena Corp PLC | SHS | G72800108 | 20,484 | 300,000 | SH | OTR | 300,000 | 0 | 0 | |||
| Rain Oncology Inc | COM | 75082Q105 | 1,383 | 1,152,212 | SH | OTR | 1,152,212 | 0 | 0 | |||
| Rapt Therapeutics Inc | COM | 75382E109 | 5,610 | 300,000 | SH | OTR | 300,000 | 0 | 0 | |||
| Reata Pharmaceuticals Inc | CL A | 75615P103 | 145,803 | 1,430,004 | SH | OTR | 1,430,004 | 0 | 0 | |||
| Relay Therapeutics Inc | COM | 75943R102 | 22,848 | 1,819,132 | SH | OTR | 1,819,132 | 0 | 0 | |||
| Revolution Medicines Inc | COM | 76155X100 | 125,304 | 4,684,264 | SH | OTR | 4,684,264 | 0 | 0 | |||
| Rocket Pharmaceuticals Inc | COM | 77313F106 | 29,130 | 1,466,051 | SH | OTR | 1,466,051 | 0 | 0 | |||
| Sage Therapeutics Inc | COM | 78667J108 | 51,440 | 1,094,000 | SH | OTR | 1,094,000 | 0 | 0 | |||
| Sarepta Therapeutics Inc | COM | 803607100 | 68,712 | 600,000 | SH | OTR | 600,000 | 0 | 0 | |||
| Selecta Biosciences Inc | COM | 816212104 | 3,678 | 3,284,072 | SH | OTR | 3,284,072 | 0 | 0 | |||
| Springworks Therapeutics Inc | COM | 85205L107 | 89,713 | 3,421,541 | SH | OTR | 3,421,541 | 0 | 0 | |||
| Surrozen Inc | *W EXP 08/01/203 | 86889P117 | 4 | 66,666 | SH | OTR | 66,666 | 0 | 0 | |||
| Tango Therapeutics Inc | COM | 87583X109 | 23,650 | 7,123,642 | SH | OTR | 7,123,642 | 0 | 0 | |||
| Theseus Pharmaceuticals Inc | COM | 88369M101 | 3,266 | 350,000 | SH | OTR | 350,000 | 0 | 0 | |||
| Third Harmonic Bio Inc | COM | 88427A107 | 2,744 | 570,417 | SH | OTR | 570,417 | 0 | 0 | |||
| Tyra Biosciences Inc | COM | 90240B106 | 109,816 | 6,448,359 | SH | OTR | 6,448,359 | 0 | 0 | |||
| Ventyx Biosciences Inc | COM | 92332V107 | 27,880 | 850,000 | SH | OTR | 850,000 | 0 | 0 | |||
| Veru Inc | COM | 92536C103 | 413 | 347,300 | SH | OTR | 347,300 | 0 | 0 | |||
| Viking Therapeutics Inc | COM | 92686J106 | 32,420 | 2,000,000 | SH | OTR | 2,000,000 | 0 | 0 | |||
| Xenon Pharmaceuticals Inc | COM | 98420N105 | 23,100 | 600,000 | SH | OTR | 600,000 | 0 | 0 | |||
| Zentalis Pharmaceuticals Inc | COM | 98943L107 | 12,695 | 450,000 | SH | OTR | 450,000 | 0 | 0 | |||